PEPCK Deficiency is a rare genetic disorder that affects the body's ability to produce an enzyme called phosphoenolpyruvate carboxykinase (PEPCK). This enzyme plays a crucial role in the process of gluconeogenesis, which is the production of glucose from non-carbohydrate sources in the body.
PEPCK Deficiency is an autosomal recessive disorder, meaning that it is caused by mutations in both copies of the PEPCK gene. Individuals with this condition inherit one mutated copy of the gene from each parent.
It is important to note that PEPCK Deficiency is not contagious. It is a genetic disorder that is passed down through families. It cannot be acquired or transmitted through contact with an affected individual.
Common symptoms of PEPCK Deficiency include severe hypoglycemia (low blood sugar), lactic acidosis, and failure to thrive. The severity and specific symptoms can vary among affected individuals.
Diagnosis of PEPCK Deficiency typically involves genetic testing to identify mutations in the PEPCK gene. Treatment options are limited, and management often focuses on controlling blood sugar levels through dietary modifications and medications.
Research is ongoing to better understand PEPCK Deficiency and develop potential therapies. Genetic counseling is recommended for individuals and families affected by this condition to understand the inheritance pattern and make informed decisions.